Axon Ventures

Aspen Neuroscience, Inc. is a biotechnology company based in San Diego, California, focused on developing induced pluripotent stem cell therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018, the company aims to create patient-specific restorative cell therapies that can alter the progression of the disease. Its product pipeline includes ANPD001, an autologous neuron replacement therapy designed for sporadic Parkinson's disease, and ANPD002, a gene-edited version targeting familial forms of the disease. By integrating innovative genomic approaches with stem cell biology, Aspen Neuroscience seeks to advance the field of personalized medicine and improve treatment outcomes for patients suffering from Parkinson's disease.

At Cradle Genomics, their mission is to provide knowledge that helps every pregnancy. They're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy. Cradle Genomics is newly formed with their headquarters based in San Diego and additional R&D operations located in Detroit. Cradle tests are based on the genetic analysis of fetal cells that are quickly collected during a first trimester visit with no risk to the mother or developing fetus.

Edico Genome Inc. develops bioinformatics processor chip that helps in DNA analysis. It offers DRAGEN bio-IT processor, a sequencing bioinformatics application-specific integrated circuit that is integrated on a PCIe form-factor card and is provided with accompanying software as a Platform-as-a-Service that is integrated directly into sequencing instruments and next-generation sequencing bioinformatics servers. The company was founded in 2013 and is based in La Jolla, California. As of May 14, 2018, Edico Genome Inc. operates as a subsidiary of Illumina, Inc.

Obalon Therapeutics, Inc. is a medical device company headquartered in Carlsbad, California, specializing in the development and commercialization of innovative devices for obesity treatment. The company is known for its Obalon Balloon System, which features a swallowable capsule containing an inflatable balloon that aids in weight loss for individuals with obesity. This system includes the Obalon Navigation System, a console that uses hardware and software to track the balloon's placement, and the Obalon Touch Inflation Dispenser, a semi-automated device for inflating the balloon after placement. Additionally, it provides a disposable canister filled with gas for inflation. Founded in 2008, Obalon has established itself as a leader in gastric balloon technology, emphasizing collaboration with clinicians to enhance treatment outcomes while prioritizing safety and performance. As of early 2020, the company operated three retail treatment centers in California.

Edico Genome Inc. develops bioinformatics processor chip that helps in DNA analysis. It offers DRAGEN bio-IT processor, a sequencing bioinformatics application-specific integrated circuit that is integrated on a PCIe form-factor card and is provided with accompanying software as a Platform-as-a-Service that is integrated directly into sequencing instruments and next-generation sequencing bioinformatics servers. The company was founded in 2013 and is based in La Jolla, California. As of May 14, 2018, Edico Genome Inc. operates as a subsidiary of Illumina, Inc.